Proshrs Ultra Nq Bio (BIB) 48.89 $BIB Look for Shares of

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Proshrs Ultra Nq Bio (BIB) 48.89 $BIB

Look for Shares of ProShares Ultra Nasdaq Biotechnology ETF to Potentially Pullback after Yesterday's 2.99% Rise
Comtex SmarTrend(R) - Tue May 31, 4:52PM CDT
ProShares Ultra Nasdaq Biotechnology ETF (NASDAQ:BIB) traded in a range yesterday that spanned from a low of $45.54 to a high of $46.80. Yesterday, the shares gained 3.0%, which took the trading range above the 3-day high of $45.15 on volume of 628,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
BIB: 48.89 (+0.55)

Watch for ProShares Ultra Nasdaq Biotechnology ETF to Potentially Pullback After Gaining 1.72% Yesterday
Comtex SmarTrend(R) - Fri May 27, 3:22PM CDT
ProShares Ultra Nasdaq Biotechnology ETF (NASDAQ:BIB) traded in a range yesterday that spanned from a low of $44.03 to a high of $45.14. Yesterday, the shares gained 1.7%, which took the trading range above the 3-day high of $45.10 on volume of 257,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
BIB: 48.89 (+0.55)

After Yesterday's Rally of 1.14% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Mon May 23, 3:18PM CDT
ProShares Ultra Nasdaq Biotechnology ETF (NASDAQ:BIB) traded in a range yesterday that spanned from a low of $41.26 to a high of $42.66. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of $41.69 on volume of 446,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
BIB: 48.89 (+0.55)

ProShares Ultra Nasdaq Biotechnology ETF Rises 1.85% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Mon Apr 18, 4:17PM CDT
ProShares Ultra Nasdaq Biotechnology ETF (NASDAQ:BIB) traded in a range yesterday that spanned from a low of $46.55 to a high of $49.05. Yesterday, the shares gained 1.9%, which took the trading range above the 3-day high of $47.93 on volume of 521,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
BIB: 48.89 (+0.55)

Watch for ProShares Ultra Nasdaq Biotechnology ETF to Potentially Pullback After Gaining 4.09% Yesterday
Comtex SmarTrend(R) - Mon Apr 04, 3:45PM CDT
ProShares Ultra Nasdaq Biotechnology ETF (NASDAQ:BIB) traded in a range yesterday that spanned from a low of $43.33 to a high of $45.17. Yesterday, the shares gained 4.1%, which took the trading range above the 3-day high of $43.44 on volume of 796,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
BIB: 48.89 (+0.55)

New Strong Buy Stocks for April 4th
Zacks Equity Research - Zacks Investment Research - Mon Apr 04, 9:14AM CDT
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Monday
ALGN: 89.15 (+3.87), BIB: 48.89 (+0.55), CNS: 43.10 (+0.05), AKG: 4.36 (+0.26), SFR: 32.76 (+0.93)

ProShares Ultra Nasdaq Biotechnology ETF Set to Possibly Pullback After Yesterday's Rally of 5.95%
Comtex SmarTrend(R) - Thu Mar 31, 2:33PM CDT
ProShares Ultra Nasdaq Biotechnology ETF (NASDAQ:BIB) traded in a range yesterday that spanned from a low of $39.13 to a high of $41.53. Yesterday, the shares gained 6.0%, which took the trading range above the 3-day high of $41.48 on volume of 560,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
BIB: 48.89 (+0.55)

ProShares Ultra Nasdaq Biotechnology ETF Has Returned 33.7% Since SmarTrend Recommendation (BIB)
Comtex SmarTrend(R) - Fri Feb 05, 5:44PM CST
SmarTrend identified a Downtrend for ProShares Ultra Nasdaq Biotechnology ETF (NASDAQ:BIB) on January 7th, 2016 at $60.55. In approximately 4 weeks, ProShares Ultra Nasdaq Biotechnology ETF has returned 33.67% as of today's recent price of $40.16.
BIB: 48.89 (+0.55)

Downtrend Call Working As ProShares Ultra Nasdaq Biotechnology ETF Stock Falls 30.1% (BIB)
Comtex SmarTrend(R) - Fri Jan 29, 5:04PM CST
SmarTrend identified a Downtrend for ProShares Ultra Nasdaq Biotechnology ETF (NASDAQ:BIB) on January 7th, 2016 at $60.55. In approximately 3 weeks, ProShares Ultra Nasdaq Biotechnology ETF has returned 30.07% as of today's recent price of $42.34.
BIB: 48.89 (+0.55)

BUYINS.NET: FXR, XIN, PRIM, HIL, MVV, BIB Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Mon Jan 25, 6:25AM CST
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of First Trust Industrials/Producer Drbls AlphaDEX Fd (NYSE:FXR), iShares MSCI EAFE Index (CAD-Hedged) (NYSE:XIN), PRIMORIS SERVICES CORPORATION (NASDAQRIM), Hill International Inc (NYSE:HIL), ProShares Ultra MidCap400 (NYSE:MVV), ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
HIL: 4.17 (-0.17), PRIM: 18.05 (+0.05), MVV: 83.31 (+0.67), BIB: 48.89 (+0.55), XIN: 5.00 (+0.01), FXR: 28.96 (-0.02)

ProShares Ultra Nasdaq Biotechnology ETF Has Returned 18.5% Since SmarTrend Recommendation (BIB)
Comtex SmarTrend(R) - Fri Jan 22, 12:48PM CST
SmarTrend identified a Downtrend for ProShares Ultra Nasdaq Biotechnology ETF (NASDAQ:BIB) on January 7th, 2016 at $60.55. In approximately 2 weeks, ProShares Ultra Nasdaq Biotechnology ETF has returned 18.46% as of today's recent price of $49.37.
BIB: 48.89 (+0.55)

BUYINS.NET: NOG, HTHT, BIB, KKR, HBM, JMP Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Fri Dec 18, 6:51AM CST
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of Nordic Oil and Gas Ltd (NYSE:NOG), China Lodging Group Ltd (NASDAQ:HTHT), ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB), KKR & Co. L.P. (NYSE:KKR), HudBay Minerals Inc (NYSE:HBM), JMP Group Inc (NYSE:JMP) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
NOG: 3.96 (+0.11), JMP: 5.42 (+0.06), BIB: 48.89 (+0.55), HBM: 5.00 (-0.07), KKR: 14.44 (-0.24), HTHT: 38.43 (-0.10)

BUYINS.NET: DFT, JKL, IYT, BIB, KKR, NOAH Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Wed Dec 02, 8:25PM CST
November 20, 2015
NOAH: 25.65 (+0.47), DFT: 47.83 (+0.43), BIB: 48.89 (+0.55), JKL: 127.38 (+0.48), KKR: 14.44 (-0.24), IYT: 140.77 (-0.37)

SmarTrend Watching for Potential Pullback in Shares of ProShares Ultra Nasdaq Biotechnology ETF After 2.04% Gain
Comtex SmarTrend(R) - Wed Nov 25, 5:25PM CST
ProShares Ultra Nasdaq Biotechnology ETF (NASDAQ:BIB) traded in a range yesterday that spanned from a low of $70.60 to a high of $72.42. Yesterday, the shares gained 2.0%, which took the trading range above the 3-day high of $72.09 on volume of 493,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
BIB: 48.89 (+0.55)

BUYINS.NET: NEPT, SBH, AIMC, CVLT, MHH, BIB Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Fri Oct 23, 8:02AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of Neptun SA (NASDAQ:NEPT), Sally Beauty Holdings Inc (NYSE:SBH), Altra Holdings Inc (NASDAQ:AIMC), CommVault Systems Inc (NASDAQ:CVLT), Mastech Holdings Inc (NYSE:MHH), ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
BIB: 48.89 (+0.55), SBH: 29.33 (+0.08), MHH: 7.67 (-0.22), CVLT: 51.74 (+0.27), AIMC: 28.40 (-0.17), NEPT: 1.09 (+0.01)

ProShares Ultra Nasdaq Biotechnology ETF Set to Possibly Pullback After Yesterday's Rally of 1.04%
Comtex SmarTrend(R) - Mon Oct 19, 4:45PM CDT
ProShares Ultra Nasdaq Biotechnology ETF (NASDAQ:BIB) traded in a range yesterday that spanned from a low of $60.36 to a high of $65.30. Yesterday, the shares gained 1.0%, which took the trading range above the 3-day high of $64.21 on volume of 2.0 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
BIB: 48.89 (+0.55)

ProShares Ultra Nasdaq Biotechnology ETF Down 6.7% Since SmarTrend Downtrend Call (BIB)
Comtex SmarTrend(R) - Mon Oct 19, 10:15AM CDT
SmarTrend identified a Downtrend for ProShares Ultra Nasdaq Biotechnology ETF (NASDAQ:BIB) on September 24th, 2015 at $68.46. In approximately 4 weeks, ProShares Ultra Nasdaq Biotechnology ETF has returned 6.71% as of today's recent price of $63.86.
BIB: 48.89 (+0.55)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Home Buying: Unmasking All the Real Budget Costs

Updated Category News Views 14

Home Buying: More Costs Than Meets the Eye Let's face it, buying a home is no stroll in the park. It's a tangled web of numbers and surprises that can leave even the savviest buyer in a daze. Thank goodness for articles like the one from HelloNation featuring Serena LoPiccolo-Smith, which make the invisible visible when it comes to the financial intricacies of home...

Continue Reading
CMC Declares Dividend Amid Complex Outlook

Updated Category News Views 24

Dividend's Not Just a Regular Check October 13, 2026, marks yet another dividend declaration by CMC. This time, they're dishing out $0.20 per share—a steady payday for loyal shareholders. That's 248 times in a row they've done this song and dance. Odds are, folks holding NYSE:CMC shares are giving the nod of approval, but it ain't just about cash; it's about stability...

Continue Reading
Trial for Former OB/GYN Arthur Park Begins in Bakersfield

Updated Category News Views 12

A Somber Day for Justice in Bakersfield There’s a buzz in the air, thick with anticipation and grief, as a trial seven years in the making kicks off in Bakersfield. It’s a significant affair, marking a turning point in a saga that’s shadowed the region with untold grief and unresolved accountability. We’re talking about the trial of Arthur Park, a former OB/GYN,...

Continue Reading
New Data on SKYRIZI Offers Hope for Crohn's Patients

Updated Category News Views 30

Treating Crohn's: New Hope on the Horizon Folks, let me tell you, the landscape for treating Crohn's disease just got a bit more interesting. AbbVie's Phase 3 AFFIRM study has brought some attention-grabbing data on the table, showcasing the potential of their drug, SKYRIZI® (risankizumab-rzaa). This ain't just another run-of-the-mill study; these results could be a...

Continue Reading
Partner Valuation Advisors Bolsters Team with Eichman

Updated Category News Views 10

Eichman Joins Partner Valuation Advisors as MD Turns out the buzz in real estate appraisal isn’t just about property values these days; it's about who's valuing them. Just ask Partner Valuation Advisors, who are realigning their chess pieces by bringing seasoned pro Justin Eichman, MAI, on board as Managing Director. Talk about playing your cards right. A Heavyweight in...

Continue Reading
Special Needs Group Partners with MAST to Enhance Accessibility

Updated Category News Views 27

Accessible Travel Takes the Spotlight Ah, the travel biz—just when you think you’ve got it all figured out, along comes a partnership like this to shake things up. Special Needs Group, the big cheese in mobility and medical equipment rentals, is teaming up with MAST Travel Network. Together, they're rolling out initiatives to make the world a bit more accessible, even...

Continue Reading
Laars Welcomes Women in Manufacturing to Facility Tour

Updated Category News Views 13

Opening Doors and Minds in Manufacturing On October 15, Laars Heating Systems throws wide open its Rochester, N.H., facility to a group that's rewriting the rulebook: women in manufacturing. It's not just another day in the life of assembly lines and engineering desks, folks. This is about giving a platform to those often sidelined in the field of boilers and water...

Continue Reading
Canada and Ukraine Fortify Defense with UGV Partnership

Updated Category News Views 19

New Defense Fronts: Canada and Ukraine Join Forces October 13, 2026, marks an important day in Ottawa's defense narrative with Dominion Dynamics and Ukraine's TENCORE kicking off a robust partnership. They're not just collaborating; they're plugging into each other's strengths to build TerMIT uncrewed ground vehicles (UGVs) on Canadian soil. These aren't gizmos you find...

Continue Reading
Simple Home Upgrades That Boost Value Fast

Updated Category News Views 16

Transform Your Home's Curb Appeal Without Breaking The Bank Every homeowner knows that feeling when you look at your house one day and think, "This could use a little something." Say you're strolling through a neighborhood in Fulton, N.Y., and notice a gem. It's not a brand new build, but it gleams with character. You bet it's had a few smart touches that could apply...

Continue Reading
Navigating Battery Compliance for AI Data Centers

Updated Category News Views 22

Untangling the Web of Global Battery Compliance Amid clamor about AI's insatiable appetite for energy storage, the rules around shipping, installing, and handling data center batteries have become a tangled web. From Waxahachie, Texas, Americase International plans to take the stage at the OCP Global Summit on October 15, 2026, to spearhead a discussion on bridging the...

Continue Reading

Top 5 Most Recently Viewed Articles

Emerging Markets React Amidst Trump’s Election Momentum

Updated Category News Views 317

Emerging Markets Experience Turbulence The shifting political landscape, particularly with Donald Trump's rising odds for election victory, has caused turmoil in emerging market stocks. Recently, these markets experienced their steepest monthly decline since early this year, igniting concerns among investors. The Impact of Trump’s Tariff Plans One of the main...

Continue Reading
Mastercard's Competitive Edge: Insights into Financial Metrics

Updated Category News Views 97

Mastercard's Competitive Analysis in Financial Services In an ever-evolving and fiercely competitive financial landscape, analyzing a company's performance is crucial for investors and industry analysts alike. This article focuses on Mastercard (NYSE: MA) and evaluates its standing among key competitors within the Financial Services industry. By examining essential...

Continue Reading
Simpson Manufacturing's Q2 2026 Results: A Solid Surge

Updated Category News Views 10

Impressive Gains Amid Firm Foundations I don't even need to sugarcoat it—Simpson Manufacturing (NYSE: SSD) is knocking it out of the park this quarter. The net sales ticked up 6.3% year-over-year, clocking in at a whopping $671.1 million. Not to mention, their income from operations soared over 20% compared to last year. That's not some modest uptick; it's a full-on...

Continue Reading
White Lodging Plans Exciting Development in Fort Worth Stockyards

Updated Category News Views 227

Transforming the Fort Worth Stockyards White Lodging, located in Merrillville, Indiana, has recently made waves in the hospitality industry with its latest acquisition of a sprawling 3.5-acre parcel in the historic Fort Worth Stockyards. This area is famed for its captivating cowboy culture, vibrant entertainment options, and bustling commerce, making it an ideal location...

Continue Reading
Essential Pharma Welcomes Duncan Ferguson as VP to Enhance Growth

Updated Category News Views 265

Essential Pharma Appoints New Vice President for Commercial Strategy Essential Pharma, a prominent global pharmaceutical company, is excited to announce the addition of Duncan Ferguson to its leadership team as Vice President, Commercial. His expertise in the pharmaceutical industry is expected to propel the company’s growth and enhance its product offerings. Driving...

Continue Reading